NEU 0.35% $20.17 neuren pharmaceuticals limited

Ann: Appendix 4C - quarterly, page-46

  1. 915 Posts.
    lightbulb Created with Sketch. 254
    That’s definitely on the cards I just guess that boils down to how much Acadia wants to “risk”.

    As for the upfront I just think the development costs being substantial (and not fully disclosed yet imo) that chewed into the upfront payments

    For ROW that is removed (somewhat ) . If you look at other territorial licensing deals they follow a similar pattern where the initial upfront is low for the first part of the deal where all development costs are covered. I will revisit some of these to see what the row deal structure looks like
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.17
Change
0.070(0.35%)
Mkt cap ! $2.578B
Open High Low Value Volume
$20.39 $20.53 $20.14 $4.102M 202.5K

Buyers (Bids)

No. Vol. Price($)
2 249 $20.15
 

Sellers (Offers)

Price($) Vol. No.
$20.31 790 1
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.